GL1X · GenesisL1 explorer

Research workbench

Potent inhibitors of NUDT5 silence hormone signaling in breast cancer

Analyse Potent inhibitors of NUDT5 silence hormone signaling in breast cancer in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5NQR
Type
protein
Length
390 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ADP-sugar pyrophosphatase
EC
3.6.1.13, 3.6.1.58, 2.7.7.96
UniProt
Q9UKK9
Ligands
958
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 23% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BADP-sugar pyrophosphatase (EC 3.6.1.13, 3.6.1.58, 2.7.7.96)protein19523% helix, 44% strandQ9UKK9

Ligands and binding sites

  • 958 · 8-(dimethylamino)-1,3-dimethyl-7-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]purine-2,6-dione · ligand · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13100.710.8440958
23280.710.8440958
3710.310.7421empty

Interfaces

1 interface between chains.

  • A–B · 3123 Ų buried · 36 hydrogen bonds · protein-protein

Compared structures

  • 5NQR · Potent inhibitors of NUDT5 silence hormone signaling in breast cancer · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.